Pulmonx dips on Wells Fargo downgrade eyeing uncertainty over management changes [Seeking Alpha]
Pulmonx Corporation (LUNG)
US:NASDAQ Investor Relations:
investor.prolunginc.com/investor-relations
Company Research
Source: Seeking Alpha
The investment firm said that its thesis has played out with recent management changes creating some uncertainty. Pulmonx on Wednesday announced that its president and CEO Glen French would retire from his positions, effective March 15, following over nine years of service to the company. French would stick around as a senior advisor to Steve Williamson, until May 1, who was appointed as the new president and CEO. Additionally, WFC analysts said, "Japan represents a significant opportunity but Pulmonx does not expect material revenue until 2026." Given the management transition, Wells Fargo preferred to move to the sidelines to see how the new CEO and CFO, when appointed, plan to adjust the strategy, possibly resetting expectations for 2024. Since the start of the year, Pulmonx has fallen about 14%, but on a 12-month basis, the stock has risen about 25%. SA's Quant ratings have marked the stock as a Hold, while sell-side analysts recommend the company as a Strong Buy. Rec
Show less
Read more
Impact Snapshot
Event Time:
LUNG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LUNG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LUNG alerts
High impacting Pulmonx Corporation news events
Weekly update
A roundup of the hottest topics
LUNG
News
- Pulmonx GAAP EPS of -$0.36 [Seeking Alpha]Seeking Alpha
- Pulmonx Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Pulmonx Reports First Quarter 2024 Financial ResultsGlobeNewswire
- Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024GlobeNewswire
- Pulmonx Co. (NASDAQ: LUNG) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $17.00 price target on the stock.MarketBeat
LUNG
Earnings
- 5/1/24 - Beat
LUNG
Sec Filings
- 5/1/24 - Form 8-K
- 4/24/24 - Form 4
- 4/22/24 - Form 144
- LUNG's page on the SEC website